Risk Factors for Mortality in Patients with Aortoesophageal Fistula Related to Aortic Lesions

Table 4

Summary of grafts used for aortic replacement.

	Total	Survivors	Nonsurvivors
Prosthetic grafts	27.6% (59/214)	43.0% (43/100)	14.0% (16/114)	<0.001
PTFE grafts	1.0% (2/201)	2.2% (2/92)	0	0.208
Dacron grafts	23.9% (48/201)	39.1% (36/92)	11.0% (12/109)	<0.001
Cryopreserved aortic allograft	10.3% (22/214)	15.0% (15/100)	6.1% (7/114)	0.042
Pericardial tube	0.5% (1/214)	1.0% (1/100)	0	0.467

PTFE: polytetrafluoroethylene.